Dexametasona comparado con pulsos de metilprednisolona en neumonía severa por COVID-19

Olmos, Matías; Fuentes, Nora.
Ciudad Autónoma de Buenos Aires; Ministerio de Salud de la Nación. Dirección de Investigación en Salud; 2021. 1 p.
Não convencional em Espanhol | ARGMSAL, BINACIS | ID: biblio-1435851

Documentos relacionados

  1. A Comparison of the Effects of Dexamethasone and Methylprednisolone, Used on Level-3 Intensive Care COVID-19 Patients, on Mortality: A Multi-Center Retrospective Study.
  2. Methylprednisolone for Heart Surgery in Infants - A Randomized, Controlled Trial.
  3. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial.
  4. Comparison of Clinical Outcome between Dexamethasone and Methyl Prednisolone in Treatment of Moderate to Severe COVID-19: A Systematic Review and Meta-Analysis.
  5. High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia.
  6. Corticosteroid safety in COVID-19 patients: a pharmacovigilance study
  7. Prolonged higher dose methylprednisolone <i>versus</i> conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS).
  8. Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study.
  9. Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.
  10. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.